Guideline definition | Study data definition | Referral criteria | |||
---|---|---|---|---|---|
DEGAM | DGfN/DGIM | NICE 2014 | KDIGO | ||
Kidney function | |||||
GFR | eGFR (ml/min) | < 30 or 30–59 b and one of the following criteria | < 45 or 45–59 and one of the following criteria | < 30 or 30–59 and one of the following criteria | < 30 or 30–59 and one of the following criteria |
GFR progression > 5 ml/min / year | mean eGFR reduction > 5 ml/min from first to second follow-up examination | x | |||
GFR progression > 5 ml/min / year or GFR reduction ≥ 25% / year | mean eGFR reduction > 5 ml/min from first to second follow-up examination or mean eGFR reduction of ≥ 25% | x | |||
GFR progression ≥ 15 ml/ min / year or GFR reduction ≥ 25% / year | mean eGFR reduction > 15 ml/min from first to second follow-up examination or mean eGFR reduction of ≥ 25% | x | |||
Hypertension refractory to treatment | |||||
BP > 150 and/or > 90 mmHg and ≥ 3 antihypertensives | BP: mean systolic BP of 2. and 3. measurement Antihypertensives: ATC-codes C02-C09 | x | x | ||
BP > 150 and/or > 90 mmHg and ≥ 4 antihypertensives | BP: mean systolic BP of 2. and 3. measurement Antihypertensives: ATC-codes C02-C09 | x | x | ||
Proteinuria | |||||
Proteinuria > 200 mg/l, subjects with diabetes: > 20 mg/l | Urine albumin dipstick category, subjects with diabetes: urine protein dipstick category | x | |||
Albuminuria ≥ 300 mg/g or ≥ 30 mg/mmol | ACR | x | |||
Proteinuria ≥ 70 mg/mmol and non-diabetic | ACR | x | |||
Albuminuria ≥ 30 mg/g or ≥ 3 mg/mmol | ACR | x | |||
ACR ≥ 30 mg/mmol and haematuria | ACR and urine dipstick category red blood cells + + | x | |||
Haematuria | |||||
Micro- or macrohematuria | urine dipstick category red blood cells + + a | x | x | ||
Haematuria without known urologic cause | urine dipstick category red blood cells + + a | x | |||
Morphologic and structural kidney abnormalities | |||||
Morphologic kidney changes | ICD-10-GM codes • at least one billing code one year prior to study examination of second follow-up (N02.-, N20.-) • at least one billing code five years prior to study examination of second follow-up (N11.-, N13.-, N26.-, N28.-, C64.-, D41.0, Q61.-, Q63.-, I70.1) | x | |||
Kidney stones | ICD-10-GM codes N20.-, at least one billing code one year prior to study examination of second follow-up | x | |||
Renal artery stenosis | ICD-10-GM code I70.1, at least one billing code five years prior to study examination of second follow-up | x | |||
Miscellaneous | |||||
Hypocalcaemia | < 2.12 mmol/l | x | |||
Hyperphosphatemia | > 1.6 mmol/l | x | |||
Abnormalities of serum potassium | Serum potassium < 3.7 mmol/l or > 5.1 mmol/l | x | |||
Inherited kidney disease | ICD-10-GM codes, at least one billing code five years prior to study examination of second follow-up (Q61.-, Q63.-) | x | x | ||
Anaemia | WHO reference values haemoglobin, female: < 7.4 mmol/l, male: < 8.1 mmol/l | x |